MOFICEPT 500 MG TAB 10

About

Moficept 500 mg, likely referring to Mycophenolate Mofetil (MMF), is a potent immunosuppressive agent primarily used to prevent organ rejection in patients who have received kidney, heart, or liver transplants. It functions by selectively inhibiting inosine monophosphate dehydrogenase (IMPDH), an enzyme critical for the de novo synthesis of guanosine nucleotides. This mechanism specifically targets and inhibits the proliferation of T and B lymphocytes, which are key components of the immune system responsible for recognizing and attacking transplanted organs. By suppressing the immune response, MMF helps to ensure the long-term survival and function of the transplanted organ.

MMF is often used in combination with other immunosuppressants, such as corticosteroids and calcineurin inhibitors, to achieve optimal immunosuppression and minimize the risk of rejection episodes. Its efficacy in preventing both acute and chronic rejection has made it a cornerstone of post-transplant therapy. Beyond transplantation, MMF is also utilized in the management of certain autoimmune diseases, including lupus nephritis, due to its ability to modulate immune cell activity.

Uses

• Prevention of organ rejection in kidney, heart, or liver transplants.
• Treatment of lupus nephritis.
• Management of certain autoimmune diseases.
• Used in combination with other immunosuppressants.

Directions For Use

Take orally, typically twice daily, on an empty stomach for consistent absorption. Follow your doctor's prescribed dosage and schedule strictly.

Benefits

• Highly effective in preventing organ transplant rejection.
• Reduces the incidence of acute rejection episodes.
• Improves long-term graft survival rates.
• Useful in managing certain autoimmune conditions.
• Allows for reduction in corticosteroid doses.
• Available in oral and intravenous formulations.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Leukopenia (low white blood cell count)
• Anemia
• Thrombocytopenia (low platelet count)
• Increased risk of infections (bacterial, viral, fungal)
• Increased risk of lymphoma and other malignancies
• Hypertension
• Headache
• Tremor

Safety Measures

• Alcohol - No direct interaction, but general caution is advised due to potential for liver effects and overall health considerations in immunosuppressed patients.
• Pregnancy - Contraindicated due to a high risk of birth defects and miscarriage. Women of childbearing potential must use effective contraception.
• Breastfeeding - Contraindicated. Mycophenolate passes into breast milk and can cause serious adverse effects in the infant.
• Liver - Use with caution; dose adjustment may be needed in severe hepatic impairment due to altered drug metabolism.
• Kidney - Dose adjustment may be needed in severe renal impairment, as drug exposure can increase. Monitor renal function closely.
• Lung - Increased risk of opportunistic lung infections (e.g., CMV pneumonia) and interstitial lung disease. Monitor for respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.